Investor Alert

London Markets Open in:

July 23, 2019, 4:35 p.m. EDT

Edwards Lifesciences shares jump after earnings

Watchlist Relevance

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Edwards Lifesciences Corp. (EW)

or Cancel Already have a watchlist? Log In

By Patrick Thomas

Edwards Lifesciences Corp.'s /zigman2/quotes/205745196/composite EW +6.00% profit fell for its second quarter but beat analysts' estimates as sales rose 15% from a year earlier.

The Irvine, Calif., medical-device maker reported a profit of $242.3 million, or $1.14 a share, compared with $282.7 million, or $1.32 a share, a year ago.

The company reported adjusted earnings of $1.38 a share. Analysts polled by FactSet were expecting earnings of $1.33 a share on an adjusted basis.

Sales rose to $1.09 billion from $943.7 million a year earlier. Analysts had expected $1.05 billion of revenue in the quarter.

The company said its sales were boosted by increased demand for its transcatheter aortic valve replacement product (Tarv). Tarv sales grew 16% to $678 million from a year earlier.

For the year, the company raised its adjusted earnings outlook to between $5.20 to $5.40 from $5.10 to $5.35 a share.

For its current quarter, the company said it expects sales between $1.02 billion and $1.06 billion, and adjusted earnings per share between $1.13 to $1.23.

Shares of the company rose 7% during after-market trading.

Write to Patrick Thomas at patrick.thomas@wsj.com

$ 71.22
+4.03 +6.00%
Volume: 4.81M
July 14, 2020 4:00p
P/E Ratio
Dividend Yield
Market Cap
$41.64 billion
Rev. per Employee

This Story has 0 Comments
Be the first to comment
More News In

Story Conversation

Commenting FAQs »
Link to MarketWatch's Slice.